Karina Svanberga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Svanberga has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Juris Jansons
Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia
3 shared publications - Nikita Zrelovs
Scientific Laboratory of Molecular Genetics, Riga Stradins University, LV-1007 Riga, Latvia
3 shared publications - Andris Kazaks
Latvian Biomedical Research and Study Centre, Riga, Latvia
2 shared publications - Aivars Bērziņš
Institute of Food Safety, Animal Health and Environment “BIOR”, LV-1076 Rīga, Latvia
1 shared publication - Andris Dislers
Latvian Biomedical Research and Study Centre, LV-1067 Riga, Latvia
1 shared publication - Chibuzor Gerald Agu
Bacteria Research National Veterinary Research Institute NVRI, Vom 930001, Nigeria
1 shared publication
Latest Publications
- Open Access
- 1 June 2025
- Published by SAGE Publications in PHAGE: Therapy, Applications, and Research
- Vol. 6 (2) , 121-132
Isolation and Characterization of a Novel Klebsiella michiganensis Bacteriophage RSU-F4K5
Background: Bacteriophage diversity of Klebsiella -infecting phages isolated on Klebsiella spp. other than Klebsiella pneumoniae remains relatively underexplored. Materials and Methods: A novel bacteriophage RSU-F4K5 infecting a Klebsiella michiganensis strain representing ST191 was isolated and characterized. The phage was subjected to Whole Genome Sequencing (WGS), genome de novo assembly, genome functional annotation, and comparative genomics. Wet-lab characterization included Transmission Electron Microscopy (TEM), lysis dynamics turbidimetry, adsorption assay, and a one-step growth curve. Results: K. michiganensis phage RSU-F4K5 is a novel lytic siphophage with a complete genome of 48,657 bp (47.71% G + C) predicted to encode 103 proteins and demonstrating Klebsiella spp. isolates other than its isolation host. Conclusions: The host-specificity demonstrated by RSU-F4K5 makes it highly unlikely to be useful for therapeutical applications. However, the isolation and characterization of phage RSU-F4K5 adds to the global knowledge of the phage diversity of Klebsiella spp.
- 1 June 2025
- Published by SAGE Publications in PHAGE: Therapy, Applications, and Research
- Vol. 6 (2) , 121-132
Open AccessIsolation and Characterization of a Novel Klebsiella michiganensis Bacteriophage RSU-F4K5
Background: Bacteriophage diversity of Klebsiella -infecting phages isolated on Klebsiella spp. other than Klebsiella pneumoniae remains relatively underexplored. Materials and Methods: A novel bacteriophage RSU-F4K5 infecting a Klebsiella michiganensis strain representing ST191 was isolated and characterized. The phage was subjected to Whole Genome Sequencing (WGS), genome de novo assembly, genome functional annotation, and comparative genomics. Wet-lab characterization included Transmission Electron Microscopy (TEM), lysis dynamics turbidimetry, adsorption assay, and a one-step growth curve. Results: K. michiganensis phage RSU-F4K5 is a novel lytic siphophage with a complete genome of 48,657 bp (47.71% G + C) predicted to encode 103 proteins and demonstrating Klebsiella spp. isolates other than its isolation host. Conclusions: The host-specificity demonstrated by RSU-F4K5 makes it highly unlikely to be useful for therapeutical applications. However, the isolation and characterization of phage RSU-F4K5 adds to the global knowledge of the phage diversity of Klebsiella spp.
- Open Access
- 25 October 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (11) , 1006
Isolation and Characterization of a Novel Jumbo Phage HPP-Temi Infecting Pseudomonas aeruginosa Pa9 and Increasing Host Sensitivity to Ciprofloxacin
Pseudomonas aeruginosa is a bacteria responsible for many hospital-acquired infections. Phages are promising alternatives for treating P. aeruginosa infections, which are often intrinsically resistant. The combination of phage and antibiotics in clearing bacterial infection holds promise due to increasing reports of enhanced effectiveness when both are used together. The aim of the study is to isolate and characterize a novel P. aeruginosa phage and determine its effectiveness in in vitro combination with antibiotics in controlling P. aeruginosa. In this study, a novel jumbo myophage HPP-Temi infecting P. aeruginosa Pa9 (PP334386) was isolated from household sewage. Electron micrographs of the phage were obtained to determine the morphological features of HPP-Temi virions. Complete genome analysis and a combination of Pseudomonas phage HPP-Temi with antibiotics were examined. The phage HPP-Temi was able to productively infect P. aeruginosa ATCC 9027 but was unable to infect a closely related genus. The phage was stable at 4–37 °C, 0.5% NaCl, and pH 8 for at least one hour. The HPP-Temi genome is a 302,719-bp-long dsDNA molecule with a GC content of 46.46%. The genome was predicted to have 436 ORFs and 7 tRNA genes. No virulence factor-related genes, antimicrobial resistance, or temperate lifestyle-associated genes were found in the phage HPP-Temi genome. Phage HPP-Temi is most closely related to the known or tentative representatives of the Pawinskivirus genus and can be proposed as a representative for the creation of a novel phage species in that genus. The phage and antibiotics (Ciprofloxacin) combination at varying phage titers (103, 106, 109) were used against P. aeruginosa Pa9 (PP334386) at 3.0 × 108 CFU/mL, which was carried out in triplicate. The result showed that combining antibiotics with phage significantly reduced the bacteria count at 103 and 106 titers, while no growth was observed at 109 PFU/mL. This suggests that the effect of phage HPP-Temi in combination with antibiotics is a potential and promising agent for the control of P. aeruginosa infections.
- 25 October 2024
- Published by MDPI AG in Antibiotics
- Vol. 13 (11) , 1006
Open AccessIsolation and Characterization of a Novel Jumbo Phage HPP-Temi Infecting Pseudomonas aeruginosa Pa9 and Increasing Host Sensitivity to Ciprofloxacin
Pseudomonas aeruginosa is a bacteria responsible for many hospital-acquired infections. Phages are promising alternatives for treating P. aeruginosa infections, which are often intrinsically resistant. The combination of phage and antibiotics in clearing bacterial infection holds promise due to increasing reports of enhanced effectiveness when both are used together. The aim of the study is to isolate and characterize a novel P. aeruginosa phage and determine its effectiveness in in vitro combination with antibiotics in controlling P. aeruginosa. In this study, a novel jumbo myophage HPP-Temi infecting P. aeruginosa Pa9 (PP334386) was isolated from household sewage. Electron micrographs of the phage were obtained to determine the morphological features of HPP-Temi virions. Complete genome analysis and a combination of Pseudomonas phage HPP-Temi with antibiotics were examined. The phage HPP-Temi was able to productively infect P. aeruginosa ATCC 9027 but was unable to infect a closely related genus. The phage was stable at 4–37 °C, 0.5% NaCl, and pH 8 for at least one hour. The HPP-Temi genome is a 302,719-bp-long dsDNA molecule with a GC content of 46.46%. The genome was predicted to have 436 ORFs and 7 tRNA genes. No virulence factor-related genes, antimicrobial resistance, or temperate lifestyle-associated genes were found in the phage HPP-Temi genome. Phage HPP-Temi is most closely related to the known or tentative representatives of the Pawinskivirus genus and can be proposed as a representative for the creation of a novel phage species in that genus. The phage and antibiotics (Ciprofloxacin) combination at varying phage titers (103, 106, 109) were used against P. aeruginosa Pa9 (PP334386) at 3.0 × 108 CFU/mL, which was carried out in triplicate. The result showed that combining antibiotics with phage significantly reduced the bacteria count at 103 and 106 titers, while no growth was observed at 109 PFU/mL. This suggests that the effect of phage HPP-Temi in combination with antibiotics is a potential and promising agent for the control of P. aeruginosa infections.
- Open Access
- 8 March 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (3) , 542
Isolation and Characterization of a Novel Aeromonas salmonicida-Infecting Studiervirinae Bacteriophage, JELG-KS1
Representatives of the bacterial genus Aeromonas are some of the most notorious aquaculture pathogens associated with a range of diseases in different fish species. As the world forges toward the post-antibiotic era, alternative options for combating bacterial pathogens are needed. One such alternative option is phage biocontrol. In this study, a novel podophage—JELG-KS1—infecting Aeromonas salmonicida was retrieved from wastewater along with its host strain. The genome of the JELG-KS1 phage is a 40,505 bp dsDNA molecule with a GC% of 53.42% and 185 bp direct terminal repeats and encodes 53 predicted proteins. Genomic analysis indicates that JELG-KS1 might represent a novel genus within the subfamily Studiervirinae. Podophage JELG-KS1 is a strictly lytic phage without any identifiable virulence or AMR genes that quickly adsorbs onto the surface of host cells to initiate a 48 min long infectious cycle, resulting in the release of 71 ± 12 JELG-KS1 progeny virions per infected cell. JELG-KS1 effectively lyses its host population in vitro, even at very low multiplicities of infection. However, when challenged against a panel of Aeromonas spp. strains associated with diseases in aquaculture, JELG-KS1 shows host-specificity that is confined only to its isolation strain, immediately compromising its potential for Aeromonas spp. biocontrol in aquaculture.
- 8 March 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (3) , 542
Open AccessIsolation and Characterization of a Novel Aeromonas salmonicida-Infecting Studiervirinae Bacteriophage, JELG-KS1
Representatives of the bacterial genus Aeromonas are some of the most notorious aquaculture pathogens associated with a range of diseases in different fish species. As the world forges toward the post-antibiotic era, alternative options for combating bacterial pathogens are needed. One such alternative option is phage biocontrol. In this study, a novel podophage—JELG-KS1—infecting Aeromonas salmonicida was retrieved from wastewater along with its host strain. The genome of the JELG-KS1 phage is a 40,505 bp dsDNA molecule with a GC% of 53.42% and 185 bp direct terminal repeats and encodes 53 predicted proteins. Genomic analysis indicates that JELG-KS1 might represent a novel genus within the subfamily Studiervirinae. Podophage JELG-KS1 is a strictly lytic phage without any identifiable virulence or AMR genes that quickly adsorbs onto the surface of host cells to initiate a 48 min long infectious cycle, resulting in the release of 71 ± 12 JELG-KS1 progeny virions per infected cell. JELG-KS1 effectively lyses its host population in vitro, even at very low multiplicities of infection. However, when challenged against a panel of Aeromonas spp. strains associated with diseases in aquaculture, JELG-KS1 shows host-specificity that is confined only to its isolation strain, immediately compromising its potential for Aeromonas spp. biocontrol in aquaculture.